These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32521002)
21. Exposure to SARS-CoV-2 in a high transmission setting increases the risk of severe COVID-19 compared with exposure to a low transmission setting? Chen D; Hu C; Su F; Song Q; Wang Z J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32502262 [No Abstract] [Full Text] [Related]
30. Response to: Eosinophil count in severe coronavirus disease 2019. Qian GQ; Zhang X; Ma AHY; Yang NB QJM; 2020 Jul; 113(7):513-514. PubMed ID: 32315421 [No Abstract] [Full Text] [Related]
31. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern? Conti CB; Henchi S; Coppeta GP; Testa S; Grassia R Eur J Intern Med; 2020 Jul; 77():147-149. PubMed ID: 32414639 [No Abstract] [Full Text] [Related]
32. Nucleic acid approaches to antibody-based therapeutics for COVID-19: A perspective. Parzych E; Weiner DB J Allergy Clin Immunol; 2020 Sep; 146(3):537-540. PubMed ID: 32623068 [No Abstract] [Full Text] [Related]
33. Histological-ultrasonographical correlation of pulmonary involvement in severe COVID-19. Almeida Monteiro RA; de Oliveira EP; Nascimento Saldiva PH; Dolhnikoff M; Duarte-Neto AN; Intensive Care Med; 2020 Sep; 46(9):1766-1768. PubMed ID: 32494927 [No Abstract] [Full Text] [Related]
34. Severe coronavirus disease 2019 in children and young adults. Wilkes M; Issa R; Aluf A; Beliard K; Yau M; Rapaport R; Ebekozien O J Pediatr; 2020 Oct; 225():280. PubMed ID: 32590002 [No Abstract] [Full Text] [Related]
35. Interferon deficiency can lead to severe COVID. Meffre E; Iwasaki A Nature; 2020 Nov; 587(7834):374-376. PubMed ID: 33139913 [No Abstract] [Full Text] [Related]
36. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2. Fagiani F; Catanzaro M; Lanni C Signal Transduct Target Ther; 2020 Aug; 5(1):170. PubMed ID: 32843617 [No Abstract] [Full Text] [Related]
37. Early prediction of the risk of severe coronavirus disease 2019: A key step in therapeutic decision making. Côté A; Ternacle J; Pibarot P EBioMedicine; 2020 Sep; 59():102948. PubMed ID: 32810827 [No Abstract] [Full Text] [Related]
38. Predicting Severe Outcomes in COVID-19. Lipworth B; Chan R; Kuo CR J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2582-2584. PubMed ID: 32615256 [No Abstract] [Full Text] [Related]
39. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. Xie Y; Cao S; Dong H; Li Q; Chen E; Zhang W; Yang L; Fu S; Wang R J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32283154 [No Abstract] [Full Text] [Related]